Logo (Elranatamab 01)
Elrexfio Injection, Solution
Product Images NDC 63539-252
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Elrexfio (NDC 63539-252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by U.s. Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (Elranatamab 02)
Principal Display Panel – 44 mg/1.1 mL Vial (Elranatamab 03)
Label for Elrexfio injection, solution, 44 mg/1.1 mL (40 mg/mL), for subcutaneous use. The label indicates it is a single-dose vial, with instructions to discard unused portion. Manufacturer shown as Pfizer Inc., New York, NY. Storage instructions specify refrigeration at 2°C to 8°C and protection from light. Product NDC 63539-252-01 and Lot/Exp number PAA207821 are also visible.*
Principal Display Panel – 44 mg/1.1 mL Vial Carton (Elranatamab 04)
Carton packaging label for Elrexfio injection, solution, 44 mg/1.1 mL (40 mg/mL) by U.S. Pharmaceuticals and manufactured by Pfizer Inc. It is a single-dose vial for subcutaneous injection, intended for healthcare provider use only. Label includes dosage form, strength, administration route, storage instructions, and a warning to discard unused portion.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
